Showing 1341-1350 of 9145 results for "".
Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Your Comprehensive Guide to Energy-Based Devices
https://practicaldermatology.com/topics/practice-management/your-comprehensive-guide-to-energy-based-devices/23146/A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.Welcome 2024: Trends to Watch in Cosmetic Surgery
https://practicaldermatology.com/topics/practice-management/welcome-2024-trends-to-watch-in-cosmetic-surgery/24030/Look for noninvasive treatments, advancements in technology, and shifting age demographics.Close Up With Gil Yosipovitch, MD
https://practicaldermatology.com/columns/physician-spotlight/close-up-with-gil-yosipovitch-md/24002/DermWire TV: Adbry Approved; Syringoma Option; Confusion over Vaccines and Injectables
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-adbry-approved-syringoma-option-confusion-over-vaccines-and-injectables/20041/Adbry (tralokinumab) from Leo Pharma is the newest biologic approved for moderate to severe atopic dermatitis in adults and is the first IL-13 blocker approved in the US. Pulse Bioscience’s nano-pulse stimulation (NPS) technology shows potential for the treatment of syringoma in a feasibility studyFive Things Every Dermatologist Should Know About Visual Content
https://practicaldermatology.com/topics/practice-management/five-things-every-dermatologist-should-know-about-visual-content/20597/Keep Your Dermatology Practice HIPAA Compliant With These 5 Photo Tips
https://practicaldermatology.com/topics/practice-management/keep-your-dermatology-practice-hipaa-compliant-with-these-5-photo-tips/20684/Recommendations for managing patient photos while preserving privacy.Physician Spotlight: Lesley Clark-Loeser, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-lesley-clark-loeser-md/23980/Currents: Updates and Innovations
https://practicaldermatology.com/programs/practical-dermatology/currents-updates-and-innovations/23832/The World Health Organization (WHO) will begin using “mpox” as a synonym for monkeypox. Both names will be used simultaneously for 1 year while “monkeypox” is phased out.